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ABSTRACT 
 
PURPOSE: To determine if participants with normal visual acuity, no ophthalmoscopically signs 
of age-related maculopathy (ARM) in both eyes and who are carriers of the CFH, LOC387715 and 
HRTA1 high-risk genotypes (“gene-positive”) have impaired rod- and cone-mediated mesopic 
visual function compared to persons who do not carry the risk genotypes (“gene-negative”). 
 
METHODS: Fifty-three Caucasian study participants (mean 55.8 ± 6.1) were genotyped for CFH, 
LOC387715/ARMS2 and HRTA1 polymorphisms. We genotyped single nucleotide polymorphisms 
(SNPs) in the CFH (rs380390), LOC387715/ARMS2 (rs10490924) and HTRA1 (rs11200638) genes 
using Applied Biosystems optimised TaqMan assays. We determined the critical fusion frequency 
(CFF) mediated by cones alone (Long, Middle and Short wavelength sensitive cones; LMS) and by 
the combined activities of cones and rods (LMSR). The stimuli were generated using a 4-primary 
photostimulator that provides independent control of the photoreceptor excitation under mesopic 
light levels. Visual function was further assessed using standard clinical tests, flicker perimetry and 
microperimetry. 
 
RESULTS: The mesopic CFF mediated by rods and cones (LMSR) was significantly reduced in 
gene-positive compared to gene-negative participants after correction for age (p=0.03). Cone-
mediated CFF (LMS) was not significantly different between gene-positive and -negative 
participants. There were no significant associations between flicker perimetry and microperimetry 
and genotype. 
 
CONCLUSIONS: This is the first study to relate ARM risk genotypes with mesopic visual 
function in clinically normal persons. These preliminary results could become of clinical 
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importance as mesopic vision may be used to document sub-clinical retinal changes in persons with 
risk genotypes and to determine whether those persons progress into manifest disease.   
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The pathomechanisms of ARM involve complex relationships between genetics, oxidative stress 
and cardiovascular environmental risk factors.
1
 The genetic contribution to age-related maculopathy 
susceptibility (risk) is well known and a number of risk genotypes have been identified to associate 
with ARM and its progression.
2-5
 Potential ARM risk genes involve single nucleotide 
polymorphisms (SNPs)
6
 and although gene carrier status can be used to determine risk, it doesn’t 
determine whether a person will progress to disease. However, in clinical practice genetic status is 
not currently used as a marker to predict the need to undertake functional vision assessments in 
ophthalmoscopically normal eyes and visual function is quantitatively monitored only after patients 
show clinical signs of eye disease. Indeed, it is not known how sub-clinical changes in visual 
function can be detected in persons with healthy eyes who are genetically at risk of ARM, nor how 
those with high-risk genes differ in visual function from age-similar healthy persons who do not 
carry the gene.  
 
In this study, we detect coding variants in the complement factor H region at chromosome 1q32 
(CFH rs380390) and at 10q26 (LOC387715/ARMS2 rs10490924 and HTRA1 rs11200638) and 
relate genetic results to mesopic visual function. Mesopic vision occurs under dim light levels 
where the rod and cone photoreceptors of the human retina simultaneously convey visual 
information, spanning approximately 3-4 log units in natural viewing environments. It is known 
that mesopic vision testing can be sensitive to the early signs of retinal disease.
7
 Our experimental 
approach uses a 4-primary photostimulator
8
 to independently control the excitation of the rod and 
cone photoreceptor classes and determines flicker thresholds under mesopic lighting conditions. 
The advantage of this approach for the detection of sub-clinical signs of ARM is that flicker 
stimulation increases metabolic demand to the neuroretina by inducing higher blood flow
9
 and 
mesopic light conditions increase the activity of all photoreceptor types (rods and cones)
10
 thereby  
increasing oxygen demand. Taken together, these conditions could promote hypoxia/ischaemia
11
 in 
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a healthy retina that is susceptible to disease. Losses in flicker sensitivity are highly predictive of 
early ARM
12
 and the development of neovascular AMD
13
 which is thought to be promoted by 
ischaemia and VEGF release.
14
 We determine whether persons with ophthalmoscopically normal 
eyes and normal visual acuity who carry the risk genotypes have poorer mesopic visual function 
compared to persons who do not carry the ARM risk genotypes. 
 
METHODS 
Participants 
Written informed consents were obtained from all participants and the study was conducted in 
accordance with the requirements of the Queensland University of Technology Human Research 
Ethics Committee and the tenets of the Declaration of Helsinki. Fifty-three healthy volunteers (28 
female and 25 male) were enrolled through advertisement in University and community 
newspapers. Participants (mean age: 55.8 ± 6.1 years; range: 46 – 68 years) had no history of ocular 
or systemic disease and underwent a complete eye examination by an ophthalmologist (BF) 
according to the inclusion and exclusion criteria (Table 1). Participants had visual acuity ≥ 20/20, 
normal colour and contrast vision and no retinal anatomical abnormalities as measured with optical 
coherence tomography (OCT) and with ophthalmoscopy. Crystalline lens and fundus grading was 
performed according to the AREDS templates and participants were excluded with any posterior 
subcapsular cataract, cortical or nuclear opacities higher than grade 1 or signs of early ARM (level 
1).
15-16
 Perimetry and mesopic vision testing was performed with the right eyes and practice trials 
were conducted to familiarise participants with the protocols. 
 
Genotyping 
Saliva samples were collected using OraGene DNA Self-Collection kits (OraGene, Canada). DNA 
was manually extracted from the participants sample using the OraGene protocol and genotyped for 
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selected polymorphisms using optimised TaqMan assays (Applied Biosystems, Foster City, CA) on 
the ABI 7300 real-time PCR machine.
17
 DNA was screened for the SNPs in CFH (rs 380390) of the 
complement factor H gene on chromosome 1q32, LOC387715 (A69S, rs10490924) also known as 
age-related maculopathy susceptibility 2 gene (ARMS2) and in the high temperature requirement 
factor A1, HTRA1 (rs11200638) gene in the region of chromosome 10q26. Gene loci 1q32 and 
10q26 have been repeatedly linked to age-related maculopathy.
2, 18
 There is controversy as to which 
SNPs on chromosome 10q26 confers risk for ARM and strong linkage disequilibrium has been 
demonstrated across this region;
18-19
 we therefore genotyped both SNPs in the ARMS2 and HTRA1 
genes. 
 
In total, 53 participants were genotyped and examined ophthalmologically. Ten participants were 
excluded from mesopic vision and perimetry testing after ophthalmological examination revealed a 
cataract >AREDS grade 1 (n=1), early ARM (n=5), congenital disc disorder (n=1), protanopia 
(n=1), macular gliosis (n=1) and intraocular lens extraction after cataract (n=1). Of the remaining 
43 participants, 28 carried one or more of the risk genotypes (“gene-positive”) and 15 had no gene 
variants (“gene-negative”). Genotyping confirmed the strong linkage disequilibrium across the 
10q26 by showing complete disequilibrium between the LOC387715 and HTRA1. The investigator 
(BF) was masked to the genetic results as genotyping was performed after the vision testing.  
 
Clinical testing 
Flicker perimetry was assessed with the Medmont Perimeter M700 (Medmont International Pty 
Ltd, Vermont, Australia)
20-21
 using the standard M700 flicker protocol. The flicker stimuli (800 ms 
duration) are equivalent to a Goldman size III (0.43°). Landers et al.
22
 describe formulae to convert 
between M700 and Humphrey visual field indices. 
 
7 
 
Standard automated perimetry was evaluated with the MP-1 Microperimeter (Nidek Technologies, 
Italy) using the MP1 Humphrey 10-2 program for equivalence to the standard Humphrey field test. 
The microperimeter allows visualization of the retinal location of the threshold measurement 
23
 and 
an autotracking system corrects the stimulus projection every 40 ms to compensate for eye 
movements. Standard perimetric indices (mean sensitivity and pattern defect) were used for 
statistical analysis of all visual field data.  
 
Optical coherence tomography (OCT) (Stratus III, Zeiss, Germany) imaging was performed in both 
eyes using 6 diagonal fast, low-density 6-mm scans (128 A scans /diagonal) and 6 diagonal slow, 
high-density 6-mm scans (512 A scans /diagonal) at 30º angles. Visual acuity (Bailey-Lovie charts), 
contrast vision (Pelli–Robson) and colour vision (Lanthony desaturated) was assessed in both eyes 
in accordance with standard procedures. 
 
Mesopic vision testing with the 4-primary photostimulator 
The photostimulator is a 2-channel, Maxwellian view optical system with four narrow bandwidth 
primary lights for each channel derived from light emitting diode  – interference filter combinations 
with dominant wavelengths of 459 nm (blue), 516 nm (greenish-yellow), 561 nm (green) and 658 
nm (red). The design and control of the photostimulator is described in detail elsewhere.
8, 24-26
 
Independent control of the excitation of the four photoreceptor types in the human eye
8
 is achieved 
using the method of silent substitution.
26
  
 
To evaluate long-, middle-, and short-wavelength-sensitive cone (L-, M-, S-cone) and Rod (R) 
activity under mesopic light levels, we investigated two types of luminance stimuli, one mediated 
by cones alone (LMS) and the other mediated by the combined activities of rod and cones (LMSR). 
The LMS stimulus modulates cone luminance signals to the postreceptoral magnocellular (MC) 
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pathway and rod excitations remain steady. Since S-cones do not contribute to luminance, 
modulating cone luminance (L+M) requires a proportional change in S-cone excitation to prevent a 
change in chromaticity.
27
 
28
 The LMSR stimuli measured combined LMS-cone and rod inputs to 
the post-receptoral MC pathway.  
 
The stimulus was a 2  circular field set within a 13  surround and positioned at 7.5  temporal 
eccentricity, the approximate locus of equal rod and cone density.
29
 Any difference in sensitivity to 
the two stimulus types reflects local rod-cone interactions (within the stimulus area) in the inferred 
MC-pathway.
27
 This configuration is important for studying persons at risk of ARM because we 
can evaluate both rod and cone function in the same retinal area; the first photoreceptor losses occur 
parafoveally in ARM.
30
 The time-averaged retinal illuminance was 33 photopic Troland (Td) with a 
chromaticity metameric to the equal-energy-spectrum [L/(L+M) = 0.667, S/(L+M) = 1.0]. 
Participants were dark adapted for 10 minutes as pilot studies indicate this was sufficient to study 
mesopic vision under our experimental conditions. Testing was performed with natural pupils 
through a 2 mm artificial pupil; refractive correction was placed on the instrument side of the 
artificial pupil if required. The critical fusion frequency (CFF) was measured for the two 
postreceptoral stimulus types modulated at 15% Michelson contrast (LMS and LMSR) using a 
paradigm developed by the co-authors.
27
 The stimulus was presented in a 1 s raised cosine envelope 
and alternated with a 1 s steady field. On each trial, the initial frequency was randomly set between 
5 Hz and 30 Hz and the observer altered the stimulus frequency using a method of adjustment to 
determine the critical fusion frequency (CFF), that is, the transitional frequency between seeing 
flicker and no-flicker (steady). Six repeats were performed for each stimulus type. 
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Statistical analysis 
We first examined the distributions of the variables that did not show major deviations from 
normality. Therefore, we used parametric tests that allowed for controlling age, an important factor 
for studying age-related maculopathy.  We performed Pearson’s correlation to determine the 
relationship between mesopic critical fusion frequency (CFF), mean sensitivity (MS) and pattern 
defect (PD) (microperimetry and flicker perimetry), retinal thickness (OCT) and age. ANOVA was 
performed to evaluate the difference between the CFF measurements, flicker perimetry, 
microperimetry and the odds ratio (OR) of the three SNPs, with age controlled. The following odds 
ratios were assigned to each genotype according to previously published values
2-3
: CFH rs380390
2
, 
GG OR = 7.4, CC+CG OR = 1; LOC387715/ARMS2 rs10490920
3
, TT OR = 6.09, GT OR = 1.35, 
GG OR = 1; HTRA1 rs11200638
3
, AA OR = 6.56, AG OR = 1.85, GG OR = 1.  
 
RESULTS 
The genotype frequencies of all tested SNPs were in Hardy-Weinberg (HWE) equilibrium as 
assessed using the HWE program.
31
 Data screening was performed and seven outliers were 
identified due to repeated fixation losses on the 4-primary photostimulator or because only the 5 Hz 
adjustment step was used to set CFF. The outliers were removed from subsequent statistical 
analysis. Of the remaining 36 participants, 11 were classified as normal (low risk homozygous, 
gene-negative) and 25 gene-positive (hetero- or homozygous carriers of either one, or more than 
one gene variant tested). Table 2 shows the individual gene variant distributions (e.g. all persons 
who were heterozygous for the LOC gene variant and not accounting for other co-existing gene 
variations in these persons). The mean values (± standard deviation) of the CFF for LMSR and 
LMS for each genotype are given in Tables 3 and 4. Note that LOC and HTRA1 CFF values are the 
same due to the linkage disequilibrium. Data demonstrate that LMSR CFF decreases in gene-
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positive compared to gene-negative participants, with the exception of the high risk homozygote 
CFH.  
 
Mean sensitivities and pattern defects were determined for microperimetry and flicker perimetry 
with four and five exclusions, respectively due to increased false positive responses. The mean 
sensitivities (MS) and pattern defects (PD) ± standard deviations for the microperimeter (n=32) 
were 17.8 dB (±0.93 SD) and -1.6 dB (±0.96 SD), respectively. The mean MS and PD for flicker 
perimetry (n=31) were 25.08 dB (±0.7) and 0.9 dB (±0.6), respectively. The values for both flicker 
and microperimetry were within normal ranges.
22, 32
 Mean central retinal thickness as measured 
with the OCT (228.6 μm ±19.6) was within normal limits in all participants.33 Microperimetry 
mean sensitivity and pattern defect were significantly correlated with age (r=-0.39, p≤0.03) and 
LMSR (r=0.42, p<0.02) (Figure 1). Figure 1 shows that lower LMSR CFF was associated with 
lower MS on the microperimeter. A significant correlation between central retinal thickness (OCT) 
age (r=-0.4, p=0.02) was found as demonstrated previously.
34
  
 
ANOVA demonstrates a significant reduction of LMSR CFF in gene-positive compared to gene-
negative participants without correction for age (F1,35=4.16, p=0.05) and after correction for age 
(F1,35=5.18, p=0.03) (Figure 2). There was no significant difference between gene-positive and 
gene-negative participants in the other clinical tests (flicker perimetry, microperimetry) as well as 
in mean retinal thickness (OCT). 
 
We conducted a sub-analysis of the individual gene variant combinations and divided those into 
five groups according to each persons’ genetic combination; group 1 included all gene-negative 
participants (n=11), group 2 consisted of all participants who were only heterozygous for 
LOC/HTRA1 (n=13), group 3 consisted of participants with only the CFH homo/heterozygous 
11 
 
variant and heterozygous for LOC/HTRA1 (n=6), group 4 included all participants with only the 
homo/heterozygous CFH variant (n=4) and group 5 consisted of persons only homozygous for the 
LOC/HTRA1 variant (n=2) (Table 5). Table 5 demonstrates the CFF results for both LMS and 
LMSR for each group and shows a trend of lower LMSR values in all groups with the risk genes 
compared to the gene-negative group. A two-sample t-test with equal variances revealed a 
significant difference for group 2 with lower LMSR CFF in participants heterozygous for the 
LOC/HTRA1 compared to group 1 (gene-negative) (p=0.01).  Groups 3-5 and in particular 
homozygotes, were not significantly different compared to group 1, most likely due to small sample 
sizes in these remaining sub-groups. 
 
DISCUSSION 
This is the first demonstration that in a randomly chosen sample with normal visual acuity and 
central visual fields and no clinical signs of ARM in both eyes, persons with ARM risk genotypes 
have on average, lower mesopic visual function after correction for age compared to those who do 
not carry the risk genotype (“gene-negative”). The reduction in rod-and cone mediated (LMSR) and 
not cone-mediated only (LMS) mesopic vision is consistent with rod dysfunction, or selective rod 
loss as demonstrated histologically, psychophysically and electrophysiologically in early ARM and 
ageing.
30, 35-36
 Previous studies demonstrate reduced rod-mediated neuroretinal function in early 
ARM sufferers that exceeds those changes associated with normal ageing.
36-37
 Delayed dark-
adaptation
35, 38
 as well as reduced scotopic sensitivity
39
 are evident in early ARM. Foveal critical 
fusion frequency is reduced under photopic light levels in advanced ARM, but is not sensitive as a 
diagnostic tool,
40
 consistent with our observation that there were no differences in the cone 
mediated (LMS) CFF in gene-positive and gene-negative participants. These preliminary results in 
persons with no signs of ARM signify rod-mediated mesopic visual function testing as important 
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for the evaluation of older persons with ARM risk genotypes, and that it may become a functional 
marker for disease.  
 
We further report a novel relationship between microperimetry and the 4-primary photostimulator 
where lower MS and PD are significantly correlated with lower LMSR CFF. Although the 
microperimeter background light level is in upper mesopic range and the achromatic test stimuli 
estimate visual sensitivity mediated by rods and cone in different states of relative sensitivity, its 
inbuilt fixation tracking system may improve the detection of functional vision changes over that of 
other conventional ophthalmic tests we performed under photopic illuminations (e.g. colour vision, 
flicker perimetry). While microperimetry results were not significantly reduced in gene-positive 
compared to gene-negative participants in this cohort, future studies in a larger cohort of older 
gene-positive participants may have increased statistical power to detect sub-clinical deficits.  
 
The SNPs identified in this study have been all related to neovascular AMD.
2-3, 41
 Ischaemia due to 
underlying cardiovascular conditions has been suggested to be a major factor in the development of 
ARM and in neovascular AMD.
1, 11, 14, 42-43
 Moreover, a recent study has identified three other gene 
variants on chromosomes 15, 16 and 22 with an increased risk of AMD that are related to the 
cholesterol metabolism and thus cardiovascular risk factors.
4
 A person with these gene variants may 
be predisposed to functional deficits due to ischaemic insults. Thus a test that increases the oxygen 
demand by both, increased photoreceptor activity (during mesopic conditions) and increased blood 
flow (during flicker stimulation) as used in our experiment, may facilitate the early detection of the 
first functional deficits.  
 
The demonstrated relationship between a risk genotype and impaired mesopic visual function in 
persons with clinically normal eyes is important because visual function may be responsive to 
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appropriate environmental manipulation such dietary and lifestyle changes.
44
 Persons with ARM 
risk genotypes who smoke or have a poor diet have an approximate doubling of the risk of ARM 
progression, compared with those who are gene-positive but do not have such environmental 
exposures.
45
 Moreover, late stages of ARM may be preventable as recent studies indicate that a 
healthy lifestyle including a healthy diet, physical activity, adequate vitamin D intake and no 
smoking can decrease the risk for developing intermediate age-related macular degeneration by 
about two-fold.
46
 These findings support our approach that the application of sensitive tests for the 
early detection and appropriate monitoring of disease is vital because risk is modifiable. Monitoring 
visual function with a quantitative test will further enable the evaluation of the effect of lifestyle 
changes on a person’s health (such as change in a person’s environmental exposures), and reduce 
the economic costs associated with the most common cause of blindness in the western world. The  
study findings may have future applications in the verification of sub-clinical ARM without genetic 
assessment.  
 
Assessing mesopic vision as an early detector of sub-clinical ARM may have potential significant 
implications in determining the pathomechanisms of the subtypes of neovascular ARM such as 
occult, classic, polypoidal choroidal vasculopathy (PCV) or retinal angiomatous proliferations 
(RAP) that are poorly understood. It has been demonstrated that different gene variants promote 
subtypes of ARM.
47-48
 Further longitudinal clinical investigation is required to study persons with 
significantly reduced mesopic vision and gene-positive carrier status to determine whether visual 
function deteriorates faster than those in the low-risk (gene-negative) group and to understand the 
relationship between genotype and phenotype by quantitatively measuring visual function related to 
genotypes to determine progression to ARM.  
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Figure Legends 
 
Figure 1. Rod and cone mediated (LMSR) critical fusion frequency (CFF) as a function of 
microperimetry (MP-1) mean sensitivity (MS). There is a significant correlation between LMSR 
CFF and MS. 
 
Figure 2. Mean LMSR CFF values for participants who were heterozygous and homozygous for 
high-risk CFH, LOC and HRTA1 SNPs are significantly lower compared to the gene-negative 
participants (asterisk). Box-and whiskers plot show the median (50
th
 percentile), inter-quartile range 
(25
th
 -75
th
 percentile) and highest and lowest values. 
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Table 1. Eligibility and ineligibility criteria 
 
Table 2.  The distribution of genotypes  
 
Gene variant Low risk 
Homozygotes (n)  
Heterozygotes (n) 
 
High risk 
Homozygotes (n) 
LOC rs10490924  n=15 (GG) n=19 (GT)  n=2 (TT) 
HRTA1 rs1120038  n=15 (GG) n=19 (AG)  n=2 (AA) 
CFH rs380390  n= 5 (GG) n=21 (CG)  n=10 (CC) 
 
Table 3. Mean (±SD) LMSR Critical Flicker Frequency (CFF) for each of the gene variants  
 
Gene variant Low risk 
Homozygotes 
Heterozygotes     High risk 
Homozygotes 
LOC rs10490924 15.3 (±1.25)       14.4 (±0.96)       14.9 (±0.95)     
HRTA1 rs1120038 15.3 (±1.25)       14.4 (±0.96)       14.9 (±0.95)     
CFH rs380390 14.8 (±1.19)  14.9 (±1.08)    
 
Table 4. Mean (±SD) LMS Critical Flicker Frequency (CFF) for each of the gene variants  
 
Gene variant Low risk 
Homozygotes 
Heterozygotes     High risk 
Homozygotes 
LOC rs10490924 19.8 (±1.07)       19.4 (±1.43)       19.7 (±1.27)     
HRTA1 rs1120038 19.8 (±1.07)       19.5 (±1.40)       19.7 (±1.27)     
CFH rs380390 19.4 (±1.17)  20.1 (±1.45)    
 
 
 
 
 
 
Eligibility criteria Ineligibility criteria 
 Age between 45 and 68 years  Aphakia or pseudophakia  
 Visual acuity ≥ 20/20 in both eyes  
 Normal colour vision both eyes (Lanthony) 
 Normal contrast vision (Pelli Robson)    
 Cataract > grade 1 (AREDS) 
 Glaucoma and/or IOP >22 mmHg 
 Diabetes and diabetic retinopathy  
 No ARM in both eyes (according to AREDS)  No venous/arterial occlusion 
 Normal OCT in both eyes 
 Normal peripheral fundus 
 Uncontrolled hypertension 
 Recent myocardial infarct/stroke 
  Uncontrolled hypercholesterinaemia 
 Major illness with chronic medication 
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Table 5. The LMSR and LMS CFF for each of the gene combinations 
 
Gene combinations (n=36) LMSR CFF LMS CFF 
Group 1 (gene-negative) (n=11) 15.4 (±1.38) 19.8 (±1.13) 
Group 2 (LOC/HTRA1 heterozygous) (n=13) *14.22 (±0.78) 19.1 (±1.19) 
Group 3 (CFH, LOC/HTRA1 heterozygous) (n=6) 14.85 (±1.25) 20.1 (±1.78) 
Group 4 (CFH only) (n=4) 15.1 (±0.92) 20.2 (±0.96) 
Group 5 (LOC/HTRA1 homozygous) (n=2) 14.9 (±0.95) 19.7 (±1.27) 
*p=0.01 compared with gene-negative participants (group 1) 
 
 
